Skip to main content
Livermore
Livermore
US stocksTW
ZHEN

Sionna Therapeutics, Inc.

SION
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0002036042

In the last 90 days, Sionna Therapeutics, Inc. insiders filed 0 open-market purchases and 1 sale; 146 institutions reported holding it in 13F filings for Q2 2026, worth $2.11B in total; Viking Global Investors is the only superinvestor holding it.

SEC filings

10-K, 10-Q, 8-K, 20-F and 40-F reports Sionna Therapeutics, Inc. filed with the SEC, newest first.

Livermore lists each filing's form, 8-K items and dates only. To read a filing, open it on SEC.gov; an 8-K's press release or other attachments, such as exhibit 99.1 for Item 2.02, are in the filing index.

SEC filings by Sionna Therapeutics, Inc.
FiledForm8-K itemsPeriodDocumentFiling index
Nov 10, 202610-Q–Sep 30, 2026SECIndex
Nov 10, 20268-K2.029.01Nov 10, 2026SECIndex
Sep 14, 20268-K2.055.028.019.01Sep 9, 2026SECIndex
Aug 10, 20268-K8.019.01Aug 10, 2026SECIndex
Aug 6, 202610-Q–Jun 30, 2026SECIndex
Aug 6, 20268-K2.029.01Aug 6, 2026SECIndex
Jun 18, 20268-K5.07Jun 17, 2026SECIndex
May 12, 202610-Q–Mar 31, 2026SECIndex
May 12, 20268-K2.029.01May 12, 2026SECIndex
Mar 2, 202610-K–Dec 31, 2025SECIndex
Mar 2, 20268-K2.029.01Mar 2, 2026SECIndex
Nov 5, 202510-Q–Sep 30, 2025SECIndex
Nov 5, 20258-K2.029.01Nov 5, 2025SECIndex
Aug 11, 202510-Q–Jun 30, 2025SECIndex
Aug 11, 20258-K2.029.01Aug 11, 2025SECIndex
Jun 13, 20258-K5.07Jun 12, 2025SECIndex
Jun 4, 20258-K7.019.01Jun 4, 2025SECIndex
May 12, 202510-Q–Mar 31, 2025SECIndex
May 12, 20258-K2.029.01May 12, 2025SECIndex
Mar 20, 202510-K–Dec 31, 2024SECIndex
Mar 20, 20258-K2.029.01Mar 20, 2025SECIndex
Feb 10, 20258-K5.039.01Feb 6, 2025SECIndex